Phenotypical variability in congenital FVII deficiency follows the ISTH-SSC severity classification guidelines: a review with illustrative examples from the clinic
- PMID: 30510462
- PMCID: PMC6250109
- DOI: 10.2147/JBM.S157633
Phenotypical variability in congenital FVII deficiency follows the ISTH-SSC severity classification guidelines: a review with illustrative examples from the clinic
Abstract
Background: One of the most common rare inherited bleeding disorders, congenital factor VII (FVII) deficiency typically has a milder bleeding phenotype than other rare bleeding disorders. Categorizing severity in terms of factor activity associated with hemophilia (severe <1%, moderate 1%-5%, mild 6%-40%) has led to the observation that bleeding phenotype does not follow closely with FVII activity. Over the past decade, large-scale global registries have investigated bleeding phenotype more thoroughly. The International Society on Thrombosis and Haemostasis has reclassified FVII deficiency as follows: severe, FVII <10%, risk of spontaneous major bleeding; moderate, FVII 10%-20%, risk of mild spontaneous or triggered bleeding; mild, FVII 20%-50%, mostly asymptomatic disease.
Case reports: Eleven illustrative cases of congenital FVII deficiency adapted from clinical practice are described to demonstrate the variability in presentation and in relation to FVII activity levels. Severe FVII deficiency usually presents at a young age and carries the risk of intracranial hemorrhage, hemarthrosis, and other major bleeds. Moderate FVII deficiency tends to present later, often in adolescence and particularly in girls as they reach menarche. Milder disease may not be apparent until found incidentally on preoperative testing, during pregnancy/childbirth, or following unexplained bleeding when faced with hemostatic challenges.
Conclusion: It is important for health care professionals to be aware of the new definitions of severity and typical presentations of congenital FVII deficiency. Failure to appreciate the risks of major bleeding, including intracerebral hemorrhage in those with FVII activity <10%, may put particularly young children at risk.
Keywords: Severity of Illness Index; blood coagulation disorders/classification; blood coagulation factors/physiology; humans’ rare diseases/classification.
Similar articles
-
Reproductive health and hemostatic issues in women and girls with congenital factor VII deficiency: A systematic review.J Thromb Haemost. 2022 Dec;20(12):2758-2772. doi: 10.1111/jth.15872. J Thromb Haemost. 2022. PMID: 36073900 Free PMC article.
-
Genotype-Phenotype Relationship among 785 Unrelated White Women with Inherited Congenital Factor VII Deficiency: A Three-Center Database Study.J Clin Med. 2023 Dec 21;13(1):49. doi: 10.3390/jcm13010049. J Clin Med. 2023. PMID: 38202056 Free PMC article.
-
Bleeding symptoms at disease presentation and prediction of ensuing bleeding in inherited FVII deficiency.Thromb Haemost. 2013 Jun;109(6):1051-9. doi: 10.1160/TH12-10-0740. Epub 2013 Mar 21. Thromb Haemost. 2013. PMID: 23571462
-
Correlation between Phenotype and Coagulation Factor Activity Level in Rare Bleeding Disorders: A Systematic Review.Semin Thromb Hemost. 2025 Mar;51(2):180-195. doi: 10.1055/s-0044-1800832. Epub 2024 Dec 5. Semin Thromb Hemost. 2025. PMID: 39638319
-
Use of global assays to understand clinical phenotype in congenital factor VII deficiency.Haemophilia. 2013 Sep;19(5):765-72. doi: 10.1111/hae.12160. Epub 2013 May 20. Haemophilia. 2013. PMID: 23682803
Cited by
-
[Consensus of Chinese expert on the diagnosis and treatment of rare bleeding disorders (version 2021)].Zhonghua Xue Ye Xue Za Zhi. 2021 Feb 14;42(2):89-96. doi: 10.3760/cma.j.issn.0253-2727.2021.02.001. Zhonghua Xue Ye Xue Za Zhi. 2021. PMID: 33858037 Free PMC article. Chinese. No abstract available.
-
Thematic Series on Clinical Cases on Haemostatic Disorders.J Blood Med. 2020 Jan 30;11:33-34. doi: 10.2147/JBM.S243153. eCollection 2020. J Blood Med. 2020. PMID: 32099497 Free PMC article. No abstract available.
-
Perioperative ROTEM® evaluation in a patient affected by severe VII factor deficiency undergoing microvascular decompression craniotomy for hemifacial spasm.J Clin Monit Comput. 2024 Dec;38(6):1431-1435. doi: 10.1007/s10877-024-01183-w. Epub 2024 Jun 8. J Clin Monit Comput. 2024. PMID: 38850455 Free PMC article.
-
Novel heterozygous F7 gene mutation (c. C1286T) associated with congenital factor VII deficiency: A case report and literature review.J Clin Lab Anal. 2022 May;36(5):e24349. doi: 10.1002/jcla.24349. Epub 2022 Mar 29. J Clin Lab Anal. 2022. PMID: 35349734 Free PMC article. Review.
-
Psychosocial Impact and Disease Management in Patients with Congenital Factor VII Deficiency.J Blood Med. 2020 Sep 11;11:297-303. doi: 10.2147/JBM.S259909. eCollection 2020. J Blood Med. 2020. PMID: 32982528 Free PMC article.
References
-
- Peyvandi F, Menegatti M, Palla R. Rare bleeding disorders: worldwide efforts for classification, diagnosis, and management. Semin Thromb Hemost. 2013;39(6):579–584. - PubMed
-
- Mannucci PM, Tuddenham EG. The hemophilias – from royal genes to gene therapy. N Engl J Med. 2001;344(23):1773–1779. - PubMed
-
- Peyvandi F, Duga S, Akhavan S, Mannucci PM. Rare coagulation deficiencies. Haemophilia. 2002;8(3):308–321. - PubMed
-
- Mariani G, Herrmann FH, Dolce A, et al. Clinical phenotypes and factor VII genotype in congenital factor VII deficiency. Thromb Haemost. 2005;93(3):481–487. - PubMed
-
- Napolitano M, di Minno MN, Batorova A, et al. Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies. Haemophilia. 2016;22(5):752–759. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous